Las Mercedes Medical Research | ClinicalTrials HQ

5 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEF	cardiovascular disorder, heart disorder, heart failure	Recruiting	Phase 2	2026-08-27		NCT06793371
Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy	Drug Resistant Epilepsy, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, brain disorder, central nervous system disorder, epilepsy, focal epilepsy, nervous system disorder, visual epilepsy	Active, not recruiting	Phase 2 / Phase 3	2026-08-13		NCT06309966
Intranasal Insulin and Glutathione as an Add-On Therapy in Parkinson's Disease	Insulin Resistance, Nutritional and Metabolic Diseases, Parkinson disease, basal ganglia disorder, brain disorder, central nervous system disorder, glucose metabolism disease, hyperinsulinism, metabolic disease, movement disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, synucleinopathy	Recruiting	Phase 2	2026-07-22		NCT05266417
Long-term Safety and Tolerability of BHV-7000	Drug Resistant Epilepsy, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, brain disorder, central nervous system disorder, epilepsy, focal epilepsy, nervous system disorder, visual epilepsy	Enrolling by invitation	Phase 2	2026-05-01		NCT06443463
A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age	COVID-19, Coronaviridae Infections, Infections, Nidovirales infectious disease, Orthocoronavirinae infectious disease, RNA Virus Infections, lung disorder, pneumonia, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease, viral pneumonia	Active, not recruiting	Phase 3	2026-04-13		NCT07300839